Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Prof. Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Associate Professor of Medical Bacteriology | Shahed University | Iran

Dr. Mohammad Hossein Ahmadi, a distinguished researcher at Shahed University, Tehran, Iran, is recognized for his impactful contributions to microbiology, infectious diseases, and biomedical sciences. He holds advanced academic training in biological and medical sciences, complemented by extensive research experience that spans cellular studies, antimicrobial resistance, and innovative therapeutic materials. Dr. Ahmadi’s research primarily focuses on antibacterial mechanisms, carbapenem-resistant pathogens, mesenchymal stem cell applications, wound-healing biomaterials, and clinical microbiology, positioning him at the forefront of efforts to address global challenges related to drug-resistant infections. Over his career, he has authored 28 peer-reviewed publications, which have collectively attracted over 297 citations, earning him an h-index of 9, reflecting both productivity and scholarly influence. His recent works—including studies on the antibacterial potential of BM-MSCs encapsulated in collagen–fibrin hydrogels and analyses of the global prevalence of carbapenem-resistant Pseudomonas aeruginosa—demonstrate his commitment to translational research with clear clinical and societal benefits. Dr. Ahmadi has collaborated with more than 50 international co-authors, highlighting his strong interdisciplinary and cross-institutional engagement. His research has contributed to advancing knowledge in infection control, biomaterials engineering, and public health, with widespread relevance to clinicians, biomedical researchers, and health-policy stakeholders. Although primarily dedicated to research, he also supports the scientific community through peer-review activities and participation in scholarly dissemination. Dr. Ahmadi’s work continues to influence emerging strategies for combating antibiotic-resistant infections and improving therapeutic outcomes, underscoring his role as an important contributor to global scientific progress.

Profiles: Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

1. Ahmadi, M. H. (2021). Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: A systematic review and meta-analysis. Antimicrobial Resistance & Infection Control.

2. Farzi, S., Rezazadeh, M., Mirhosseini, A., Rezazadeh, M. A., Houshyar, F., & Ahmadi, M. H. (2021). Genetic diversity of healthcare-associated methicillin-resistant Staphylococcus aureus isolates from Southern Iran. Acta Microbiologica et Immunologica Hungarica.

3. Ahmadi, M. H. (2021). Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy.

4. Ahmadi, M. H. (2020). Indicated and non-indicated antibiotic administration during pregnancy and its effect on pregnancy outcomes: Role of inflammation. International Immunopharmacology.

5. Ahmadi, M. H. (2020). Frequency of antimicrobial resistance and class 1 and 2 integrons in Escherichia coli strains isolated from urinary tract infections. Iranian Journal of Pharmaceutical Research.

Dr. Mirjana Popadic | Skin Cancer Prevention | Best Researcher Award

Dr. Mirjana Popadic | Skin Cancer Prevention | Best Researcher Award

Dermatologist-Oncologist | Medigroup | Serbia

Dr. Mirjana Popadic is a researcher affiliated with the University of Belgrade, Serbia, where she has established a growing academic profile in her field.  Over her career, Dr. Popadic has authored 15 scholarly publications, which have collectively received 121 citations from 99 documents, demonstrating the steady influence of her contributions and culminating in an h-index of 7. Her work spans several key research domains, reflecting interdisciplinary strength and a commitment to advancing scientific understanding within her specialty. Through collaborations with at least nine co-authors, she has contributed to studies that highlight collaborative scientific inquiry and cross-disciplinary relevance. Her publications, indexed in reputable international venues, cover impactful themes aligned with contemporary scientific priorities, positioning her as an emerging scholar whose research continues to gain recognition within the academic community. Although no awarded grants or editorial roles are listed in the provided record, her publication performance and citation trajectory underscore her potential for expanded leadership roles in future scientific initiatives. Dr. Popadics scholarly output reflects methodological rigor, thematic relevance, and a commitment to addressing meaningful research questions. Her growing citation footprint indicates that her work is not only referenced but also utilized by peers for further advancements, contributing to broader scientific development. Through her contributions at the University of Belgrade, she continues to support the advancement of knowledge, strengthen collaborative networks, and contribute to the international visibility of Serbian research. With sustained productivity and a demonstrated record of influence, Dr. Popadic represents a dedicated academic whose work carries both scientific and societal impact.

Profiles: Scopus | ORCID

Featured Publications

1. Popadić, M. (2018). Dermatoscopy of multiple piloleiomyomas with disseminated and segmental distribution. Indian Journal of Dermatology, Venereology and Leprology.

2. Popadić, M. (2018). Cutaneous Polyarteritis Nodosa: Uncommon and Rare Form of Cutaneous Vasculitis. Serbian Journal of Dermatology and Venereology.

3. Popadić, M. (2015). Dermoscopy of aggressive basal cell carcinomas. Indian Journal of Dermatology, Venereology and Leprology.

4. Popadić, M., & Vukićević, J. (2015). What is the impact of tumour size on dermoscopic diagnosis of BCC? Journal of the European Academy of Dermatology and Venereology.

5. Popadić, M. (2015). Dermoscopy of cutaneous Abrikossoff tumor (granular cell tumor) in a pediatric patient. Journal of the American Academy of Dermatology.